LAS VEGAS, NV - (NewMediaWire) - June 03, 2024 - Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a regenerative medicine company, is pleased to announce an update to the progress of its significant expansion of operations into the United Arab Emirates (UAE). This expansion follows the recent approval of the flagship product, Cellgenic Exosomes, by the regional healthcare authority earlier this year, and the establishment of a cutting-edge Regenerative Medicine Clinic and Laboratory, set to begin operating in September 2024. 

The new clinic, named ReGen Dubai, will be part of the renowned ReGen Network and will be located in the prestigious Hyatt Hotel in Jumeirah. The Company expects that ReGen Dubai will become a beacon of advanced medical treatments in the region. Specializing in next-generation regenerative medicine, the clinic will offer a comprehensive suite of services focusing on age management, biohacking, longevity, cosmetic surgery and a variety of other innovative treatment options. The Company believes this strategic placement in a luxurious and accessible location ensures that patients receive top-tier care in a comfortable and exclusive environment. 

Equipped with the latest technology in stem cell therapy and regenerative medicine, the laboratory is designed to support the clinic's mission of delivering highly effective treatments for a wide range of conditions. Patients can expect personalized and cutting-edge therapies that aim to significantly enhance quality of life. 

To celebrate this expansion, the sister company, the International Society for Stem Cells Application (ISSCA), will host an inaugural conference coinciding with the official grand opening ceremony of ReGen Dubai and the laboratory in November. This prestigious event is expected to draw hundreds of physicians from GCC countries, providing a unique platform to discuss the latest advancements in regenerative medicine and stem cell therapy. The conference will also facilitate invaluable networking opportunities with the newly established clinic. 

The conference will feature presentations and workshops led by top doctors and scientists from around the world, who will share extensive knowledge and insights with attendees. This event underscores Global Stem Cells Group's commitment to fostering collaboration and advancing medical knowledge within the region. 

Dr. Salih Yildirim, Chief Operating Officer of Global Stem Cells Group, stated, "We are thrilled to bring expertise and innovative treatments to the UAE. This expansion is a testament to our commitment to global leadership in regenerative medicine. ReGen Dubai will provide unparalleled medical care, and we look forward to collaborating with regional healthcare professionals to advance the field." 

This strategic expansion into the UAE signifies Global Stem Cells Group's dedication to becoming a major player in the GCC region, mirroring the established presence in Europe, Southeast Asia, and Latin America. The aim is to lead the way in providing transformative health solutions and to set new standards in regenerative medicine and cell therapy. 

Please see this and other Company filings at www.sec.gov. 

About Meso Numismatics: Meso Numismatics Corp is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary Global Stem Cells Group. Global Stem Cells Group is a leading provider of regenerative medicine solutions, dedicated to advancing healthcare through innovative patient therapies. With a global presence and a multidisciplinary team of experts, the organization strives to harness the potential of stem cells and regenerative medicine to improve patient outcomes across various medical fields. Through its extensive network of clinics, research facilities, and training centers, Global Stem Cells Group is committed to pushing the boundaries of regenerative medicine and making a positive impact on global healthcare. The Company also distributes stem cells and other regenerative based cell lines, and equipment internationally and likewise specializes in education and training physicians in the area of regenerative medicine.  

For more information on Global Stem Cells Group please visit: www.stemcellsgroup.com 

Forward-Looking Statements 

Some information in this document constitutes forward-looking statements or statements which may be deemed or construed to be forward-looking statements, such as the closing of the share exchange agreement. The words “plan”, "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to the Company herein, including those related to the opening of the Regenerative Medicine Clinic and Laboratory and its ability to expand into the UAE markets for regenerative care, are expressly qualified in their entirety by the above-mentioned cautionary statement. The Company disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law. 

For further information, please contact: 

Investor.relations@mssvinc.com  

Telephone: (800) 956-3935